[HTML][HTML] Lck Function and Modulation: Immune Cytotoxic Response and Tumor Treatment More Than a Simple Event

JB De Sanctis, JV Garmendia, H Duchová, V Valentini… - Cancers, 2024 - mdpi.com
Simple Summary Lck is an important kinase that plays a key role in the physiological
responses of T lymphocytes as well as in several other tissues such as the lung, intestine …

Transcriptomic profiling of Iris tissue highlights LCK signaling and T cell-mediated immunity in behcet's uveitis

Y Deng, Y Zhang, T Cai, Q Wang, W Zhang… - Journal of …, 2022 - Elsevier
Uveitis is the most common form of ocular lesions in Behcet's disease, severely affecting
visual function. Molecular pathological changes of ocular lesions in patients with Behcet's …

Lck signaling inhibition causes improvement in clinical features of psoriatic inflammation through reduction in inflammatory cytokines in CD4+ T cells in imiquimod …

NO Al-Harbi, SF Ahmad, M Almutairi, AZ Alanazi… - Cellular …, 2022 - Elsevier
Psoriasis is a chronic dermal inflammatory disease with a world-wide prevalence in which
different immune/non-immune cells, eg T cells, macrophages, neutrophils, and keratinocytes …

All-photonic kinase inhibitors: light-controlled release-and-report inhibition

CL Fleming, C Benitez-Martin, E Bernson, Y Xu… - Chemical …, 2024 - pubs.rsc.org
Light-responsive molecular tools targeting kinases affords one the opportunity to study the
underlying cellular function of selected kinases. In efforts to externally control lymphocyte …

SOHO state of the art updates and next questions| new pathways and new targets in PTCL: staying on target

SA Carty, CA Murga-Zamalloa, RA Wilcox - Clinical Lymphoma Myeloma …, 2023 - Elsevier
While the peripheral T-cell lymphomas (PTCL) remain a therapeutic challenge, and
increasingly account for a disproportionate number of lymphoma-related deaths, improved …

[HTML][HTML] LCK-safescreen-model: an advanced ensemble machine learning approach for estimating the binding affinity between compounds and LCK target

Y Cheng, C Ji, J Xu, R Chen, Y Guo, Q Bian, Z Shen… - Molecules, 2023 - mdpi.com
The lymphocyte-specific protein tyrosine kinase (LCK) is a critical target in leukemia
treatment. However, potential off-target interactions involving LCK can lead to unintended …

Discovery of a Novel and Potent LCK Inhibitor for Leukemia Treatment via Deep Learning and Molecular Docking

H Guo, Z Shen, Y Yuan, R Chen, J Yang… - Journal of Chemical …, 2024 - ACS Publications
The lymphocyte-specific protein tyrosine kinase (LCK) plays a crucial role in both T-cell
development and activation. Dysregulation of LCK signaling has been demonstrated to drive …

[HTML][HTML] Scaffold repurposing reveals new nanomolar phosphodiesterase type 5 (pde5) inhibitors based on pyridopyrazinone scaffold: Investigation of in vitro and in …

KM Amin, OM El-Badry, DE Abdel Rahman… - Pharmaceutics, 2022 - mdpi.com
Inhibition of PDE5 results in elevation of cGMP leading to vascular relaxation and reduction
in the systemic blood pressure. Therefore, PDE5 inhibitors are used as antihypertensive and …

Fenretinide induces apoptosis and synergises the apoptosis inducing effect of gemcitabine through inhibition of key signalling molecules involved in A549 cell survival …

HA Al-Bustany, HA Muhammad, MA Chawsheen… - Cellular …, 2023 - Elsevier
Fenretinide is a synthetic retinoid compound, which induces apoptosis via generating
reactive oxygen species (ROS) and modulating PI3K/Akt/mTOR signalling pathway. We …

[HTML][HTML] Development of new meridianin/leucettine-derived hybrid small molecules as nanomolar multi-kinase inhibitors with antitumor activity

MH Elsherbeny, A Elkamhawy, H Nada, MH Abdellattif… - Biomedicines, 2021 - mdpi.com
Although the sea ecosystem offers a broad range of bioactivities including anticancer, none
of the FDA-approved antiproliferative protein kinase inhibitors are derived from a marine …